{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T20:21:15Z","timestamp":1769113275024,"version":"3.49.0"},"reference-count":23,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T00:00:00Z","timestamp":1768780800000},"content-version":"vor","delay-in-days":2901,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T00:00:00Z","timestamp":1518134400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,6,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Aims<\/jats:title>\n                    <jats:p>Methods to identify patients at risk for incident HF would be welcome as such patients might benefit from earlier interventions.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods and results<\/jats:title>\n                    <jats:p>From a registry of 1251 patients referred for coronary and\/or peripheral angiography, we sought to identify independent predictors of incident HF during follow-up and develop a clinical and biomarker strategy to predict this outcome. There were 991 patients free of prevalent HF at baseline. Cox proportional hazard models were developed to predict adjudicated diagnosis of incident HF. Model discrimination and reclassification were evaluated. At follow-up, 177 (18%) developed new-onset HF. Independent predictors of new-onset HF included five clinical variables (age, male sex, heart rate, history of atrial fibrillation\/flutter, and history of hypertension) and two biomarkers (amino-terminal pro-B type natriuretic peptide and ST2). The c-statistic for the model without biomarkers was 0.69; including biomarkers increased the c-statistic to 0.76 (P &amp;lt; 0.001). A score was developed from the model. Patients in the highest score quintile had shortest time to incident HF compared with lower quintiles (log-rank P &amp;lt; 0.001). Following 100 bootstrap iterations, internal validation was confirmed with Harrell's c-statistic of 0.77. Use of angiotensin-converting enzyme inhibitors, angiotensin receptor blockers, and beta-blockers at enrollment was associated with substantial attenuation of predictive value of the risk score.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Patients undergoing coronary\/peripheral angiographic procedures are a population at high risk for incident HF. We describe an accurate clinical and biomarker strategy for predicting incident HF and possibly intervening in such patients (NCT00842868).<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/ehf2.12268","type":"journal-article","created":{"date-parts":[[2018,2,9]],"date-time":"2018-02-09T06:12:50Z","timestamp":1518156770000},"page":"240-248","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Predicting New-Onset HF in Patients Undergoing Coronary or Peripheral Angiography: Results from the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) Study"],"prefix":"10.1093","volume":"5","author":[{"given":"Nasrien E.","family":"Ibrahim","sequence":"first","affiliation":[{"name":"Cardiology Division, Massachusetts General Hospital , Boston, MA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asya","family":"Lyass","sequence":"additional","affiliation":[{"name":"Baim Institute for Clinical Research , Boston, MA ,","place":["USA"]},{"name":"Department of Mathematics and Statistics, Boston University , Boston, MA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanna K.","family":"Gaggin","sequence":"additional","affiliation":[{"name":"Cardiology Division, Massachusetts General Hospital , Boston, MA ,","place":["USA"]},{"name":"Baim Institute for Clinical Research , Boston, MA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuyin","family":"Liu","sequence":"additional","affiliation":[{"name":"Baim Institute for Clinical Research , Boston, MA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roland R.J.","family":"van Kimmenade","sequence":"additional","affiliation":[{"name":"Cardiology Division, Radboud University Medical Center , Nijmegen ,","place":["The Netherlands"]},{"name":"Cardiology Division, Maastricht University Medical Center , Maastricht ,","place":["The Netherlands"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shweta R.","family":"Motiwala","sequence":"additional","affiliation":[{"name":"Cardiology Division, Brigham and Women's Hospital , Boston, MA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noreen P.","family":"Kelly","sequence":"additional","affiliation":[{"name":"Cardiology Division, Brigham and Women's Hospital , Boston, MA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Parul U.","family":"Gandhi","sequence":"additional","affiliation":[{"name":"Cardiology Division, VA Connecticut Healthcare System and Yale University , New Haven, CT ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mandy L.","family":"Simon","sequence":"additional","affiliation":[{"name":"Cardiology Division, Massachusetts General Hospital , Boston, MA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianna M.","family":"Belcher","sequence":"additional","affiliation":[{"name":"Cardiology Division, Massachusetts General Hospital , Boston, MA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jamie E.","family":"Harisiades","sequence":"additional","affiliation":[{"name":"Cardiology Division, Massachusetts General Hospital , Boston, MA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph M.","family":"Massaro","sequence":"additional","affiliation":[{"name":"Baim Institute for Clinical Research , Boston, MA ,","place":["USA"]},{"name":"Department of Biostatistics, Boston University , Boston, MA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph B.","family":"D'Agostino","sequence":"additional","affiliation":[{"name":"Baim Institute for Clinical Research , Boston, MA ,","place":["USA"]},{"name":"Department of Mathematics and Statistics, Boston University , Boston, MA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr","given":"James L.","family":"Januzzi","sequence":"additional","affiliation":[{"name":"Cardiology Division, Massachusetts General Hospital , Boston, MA ,","place":["USA"]},{"name":"Baim Institute for Clinical Research , Boston, MA ,","place":["USA"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2018,2,9]]},"reference":[{"key":"2026012115114054700_ehf212268-bib-0001","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1161\/CIRCRESAHA.115.306825","article-title":"Epidemiology of obesity and diabetes and their cardiovascular complications","volume":"118","author":"Bhupathiraju","year":"2016","journal-title":"Circ Res"},{"key":"2026012115114054700_ehf212268-bib-0002","first-page":"e38","volume-title":"Heart Disease and Stroke Statistics\u20142016 Update. A report from the American Heart Association","author":"Mozaffarian","year":"2016"},{"key":"2026012115114054700_ehf212268-bib-0003","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/CIRCULATIONAHA.111.031161","article-title":"Home monitoring should be the central element in an effective program of heart failure disease management","volume":"125","author":"Konstam","year":"2012","journal-title":"Circulation"},{"key":"2026012115114054700_ehf212268-bib-0004","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1161\/CIRCULATIONAHA.111.031179","article-title":"Home monitoring heart failure care does not improve patient outcomes: looking beyond telephone-based disease management","volume":"125","author":"Desai","year":"2012","journal-title":"Circulation"},{"key":"2026012115114054700_ehf212268-bib-0005","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1016\/j.jacc.2013.05.020","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: executive summary: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"2026012115114054700_ehf212268-bib-0006","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/archinte.159.11.1197","article-title":"Profile for estimating risk of heart failure","volume":"159","author":"Kannel","year":"1999","journal-title":"Arch Intern Med"},{"key":"2026012115114054700_ehf212268-bib-0007","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1161\/CIRCHEARTFAILURE.108.768457","article-title":"Incident heart failure prediction in the elderly: the health ABC heart failure score","volume":"1","author":"Butler","year":"2008","journal-title":"Circ Heart Fail"},{"key":"2026012115114054700_ehf212268-bib-0008","article-title":"Prediction of incident heart failure in general practice: the ARIC study","author":"Agarwal","year":"2012","journal-title":"Circulation: Heart Failure"},{"key":"2026012115114054700_ehf212268-bib-0009","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1093\/eurjhf\/hfq115","article-title":"The Intermountain Risk Score (including the red cell distribution width) predicts heart failure and other morbidity endpoints","volume":"12","author":"Horne","year":"2010","journal-title":"Eur J Heart Fail"},{"key":"2026012115114054700_ehf212268-bib-0010","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1161\/CIRCHEARTFAILURE.114.001478","article-title":"Von Willebrand factor improves risk prediction in addition to N-terminal pro\u2013B-type natriuretic peptide in patients referred to coronary angiography and signs and symptoms of heart failure and preserved ejection fraction","volume":"8","author":"Kleber","year":"2015","journal-title":"Circ Heart Fail"},{"key":"2026012115114054700_ehf212268-bib-0011","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1002\/ejhf.104","article-title":"C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction","volume":"16","author":"Koller","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026012115114054700_ehf212268-bib-0012","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijcme.2014.08.005","article-title":"Design, methods, baseline characteristics and interim results of the Catheter Sampled Blood Archive in Cardiovascular Diseases (CASABLANCA) study","volume":"5","author":"Gaggin","year":"2014","journal-title":"IJC of Metabolic & Endocrine"},{"key":"2026012115114054700_ehf212268-bib-0013","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure: The Task Force for the diagnosis and treatment of acute and chronic heart failure of the European Society of Cardiology (ESC). Developed with the special contribution of the Heart Failure Association (HFA) of the ESC","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"2026012115114054700_ehf212268-bib-0014","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1001\/archinte.166.3.315","article-title":"Utility of amino-terminal pro-brain natriuretic peptide testing for prediction of 1-year mortality in patients with dyspnea treated in the emergency department","volume":"166","author":"Januzzi","year":"2006","journal-title":"Arch Intern Med"},{"key":"2026012115114054700_ehf212268-bib-0015","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.cca.2009.08.010","article-title":"Analytical and clinical evaluation of a novel high-sensitivity assay for measurement of soluble ST2 in human plasma\u2014the Presage\u2122 ST2 assay","volume":"409","author":"Dieplinger","year":"2009","journal-title":"Clin Chim Acta"},{"key":"2026012115114054700_ehf212268-bib-0016","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/sim.1742","article-title":"Presentation of multivariate data for clinical use: the Framingham Study risk score functions","volume":"23","author":"Sullivan","year":"2004","journal-title":"Stat Med"},{"key":"2026012115114054700_ehf212268-bib-0017","first-page":"504","volume-title":"Estimating Harrell's optimism on predictive indices using bootstrap samples","author":"Miao","year":"2013"},{"key":"2026012115114054700_ehf212268-bib-0018","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1161\/CIRCULATIONAHA.110.979500","article-title":"Natriuretic peptide testing in heart failure","volume":"123","author":"Kim","year":"2011","journal-title":"Circulation"},{"key":"2026012115114054700_ehf212268-bib-0019","doi-asserted-by":"crossref","first-page":"70B","DOI":"10.1016\/j.amjcard.2015.01.044","article-title":"ST2 testing for chronic heart failure therapy monitoring: the International ST2 Consensus Panel","volume":"115","author":"Januzzi","year":"2015","journal-title":"Am J Cardiol"},{"key":"2026012115114054700_ehf212268-bib-0020","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1161\/CIRCHEARTFAILURE.114.001185","article-title":"Clinical risk stratification optimizes value of biomarkers to predict new-onset heart failure in a community-based cohort","volume":"7","author":"Brouwers","year":"2014","journal-title":"Circ Heart Fail"},{"key":"2026012115114054700_ehf212268-bib-0021","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/eurjhf\/hft124","article-title":"N-terminal pro brain natriuretic peptide but not copeptin improves prediction of heart failure over other routine clinical risk parameters in older men with and without cardiovascular disease: population-based study","volume":"16","author":"Goya Wannamethee","year":"2014","journal-title":"Eur J Heart Fail"},{"key":"2026012115114054700_ehf212268-bib-0022","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.jacc.2005.08.051","article-title":"Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the proBNP investigation of dyspnea in the emergency department (PRIDE) study","volume":"47","author":"Anwaruddin","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"2026012115114054700_ehf212268-bib-0023","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/j.jacc.2006.06.056","article-title":"Amino-terminal pro-brain natriuretic peptide, renal function, and outcomes in acute heart failure: redefining the cardiorenal interaction?","volume":"48","author":"van Kimmenade","year":"2006","journal-title":"J Am Coll Cardiol"}],"container-title":["ESC Heart Failure"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fehf2.12268","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/5\/3\/240\/66137060\/eschf_5_3_240.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/eschf\/article-pdf\/5\/3\/240\/66137060\/eschf_5_3_240.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:15:26Z","timestamp":1769026526000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/eschf\/article\/5\/3\/240\/8403799"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2,9]]},"references-count":23,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2018,2,9]]},"published-print":{"date-parts":[[2018,6,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ehf2.12268","relation":{},"ISSN":["2055-5822"],"issn-type":[{"value":"2055-5822","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,6]]},"published":{"date-parts":[[2018,2,9]]},"assertion":[{"value":"2017-09-14","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-12-31","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-02-09","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}